Medicines 
Dealstreet

Samisti Legal, Trilegal act on Piramal Pharma acquiring minority stake in Yapan Bio for ₹101.77 crore

The acquisition took place through primary and secondary purchase of shares.

Bar & Bench

Piramal Pharma acquires minority stake in Yapan Bio for ₹101.77 crore.

Samisti Legal acted as the legal counsel to Yapan Bio. The team was led by Prashant Jain (Partner) and assisted by Anita Dugar (Principal Associate).

Trilegal acted for Piramal Pharma.

The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its Contract Development and Manufacturing Organization (CDMO) business, by broadening its service offerings.

The acquisition took place through primary and secondary purchase of shares.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Dushyant Dave quits legal profession after 48 years

When lawyering becomes criminal: The Supreme Court's chance to protect the defenders of rule of law

'Intention' and the dynamics of caste abuse in the Atrocities Act

Don't burden yourself with loan for foreign LL.M: CJI BR Gavai to law graduates

Swiss Army Knife maker gets urgent relief from Bombay HC against unauthorised listings on Amazon

SCROLL FOR NEXT